Canada will start sending more than 1,000 doses of an experimental Ebola vaccine to Switzerland this week as part of the global fight against the deadly virus, a Geneva hospital said Sunday.
Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.
Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work.
High drug expenses in Canada are a substantial barrier for people to access prescription drugs outside of hospital, states an analysis in CMAJ (Canadian Medical Association Journal).
(Medical Xpress)—Drug-impaired driving is a growing problem in Canada that remains dramatically under-enforced and, if enforced at all, is time-consuming, unwieldy and fails to identify the vast majority of drug-impaired ...
Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation in developing new drugs, states an analysis in CMAJ (Canadian Medical Association Journal).
Alternative funding for health care in Canada will not result in lower costs nor contribute to financial sustainability, states a commentary in CMAJ (Canadian Medical Association Journal).